Medtronic invests $700M in Cornerstone Robotics
Analysis based on 19 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026
On September 1, 2026, Medtronic announced a strategic partnership with Cornerstone Robotics, a China — Hong Kong-based surgical robotics company. Medtronic will make an approximately $700 million investment in Cornerstone Robotics, gaining rights to distribute Cornerstone's Sentire surgical system in select markets outside the U.S. where the system is approved. Medtronic will offer Sentire alongside its Hugo robotic-assisted surgery (RAS) system, creating a two-platform portfolio combined with Medtronic's connected surgical ecosystem. The partnership aims to expand global access to robotic-assisted surgery, which currently has adoption in the single digits. Sentire has received CE Mark in the European Union and approvals in China and Singapore for minimally invasive general, gynecologic, thoracic, and urologic procedures. Medtronic's Hugo system is used in over 35 countries, with procedures expected to exceed 50,000 by the end of fiscal 2026. The investment strengthens Medtronic's surgical portfolio and provides Cornerstone Robotics with capital and global distribution capabilities. Morgan Stanley served as financial advisor to Medtronic, with Cleary Gottlieb as legal counsel; Kirkland & Ellis and Global Law Office advised Cornerstone Robotics.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard